[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
June 2012

Evaluating Therapeutic HypothermiaParental Perspectives Should Be Explicitly Represented in Future Research

Author Affiliations

Author Affiliations: WINNER Centre for Newborn Research, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown (Dr Tarnow-Mordi), Miracle Babies Foundation, Moorebank (Ms Cruz), New South Wales, and Robinson Institute, Discipline of Obstetrics and Gynecology, Women's and Children's Hospital, University of Adelaide, Adelaide, South Australia (Dr Wilkinson), Australia.

Arch Pediatr Adolesc Med. 2012;166(6):578-579. doi:10.1001/archpediatrics.2012.314

The systematic review of randomized controlled trials by Tagin et al in this issue of the Archives1 confirms therapeutic hypothermia, or cooling, as a major advance for infants with hypoxic ischemic encephalopathy (HIE). The evidence, achieved during 2 decades of international collaboration, reflects great credit on the neonatal community, parents, researchers, funding agencies, and providers of health care.

First Page Preview View Large
First page PDF preview
First page PDF preview